Literature DB >> 21913733

Synthesis and evaluation of a fluorescent ritterazine-cephalostatin hybrid.

Kanduluru Ananda Kumar1, James J La Clair, Philip L Fuchs.   

Abstract

The cephalostatin and ritterazine natural products comprise a potent family of bis-steroidal pyrazines that display potent single-digit nanomolar inhibition of tumor cell growth. An active fluorescent ritterazine-cephalostatin hybrid probe was developed using detailed SAR data derived through total synthetic efforts. A combination of time course and confocal imaging studies indicate that this natural product family is rapidly taken up in tumor cells and localizes subcellularly within ER and surrounding the nuclear-ER interface.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913733      PMCID: PMC3264888          DOI: 10.1021/ol202139z

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  19 in total

1.  An optimized immunoaffinity fluorescent method for natural product target elucidation.

Authors:  Wei-Luen Yu; Gianni Guizzunti; Timothy L Foley; Michael D Burkart; James J La Clair
Journal:  J Nat Prod       Date:  2010-09-13       Impact factor: 4.050

Review 2.  Natural product mode of action (MOA) studies: a link between natural and synthetic worlds.

Authors:  James J La Clair
Journal:  Nat Prod Rep       Date:  2010-04-26       Impact factor: 13.423

3.  Natural products reveal cancer cell dependence on oxysterol-binding proteins.

Authors:  Anthony W G Burgett; Thomas B Poulsen; Kittikhun Wangkanont; D Ryan Anderson; Chikako Kikuchi; Kousei Shimada; Shuichi Okubo; Kevin C Fortner; Yoshihiro Mimaki; Minpei Kuroda; Jason P Murphy; David J Schwalb; Eugene C Petrella; Ivan Cornella-Taracido; Markus Schirle; John A Tallarico; Matthew D Shair
Journal:  Nat Chem Biol       Date:  2011-08-07       Impact factor: 15.040

4.  On the relationship of OSW-1 to the cephalostatins.

Authors:  C Guo; T G LaCour; P L Fuchs
Journal:  Bioorg Med Chem Lett       Date:  1999-02-08       Impact factor: 2.823

5.  On topography and functionality in the B-D rings of cephalostatin cytotoxins.

Authors:  T G LaCour; C Guo; S Ma; J U Jeong; M R Boyd; S Matsunaga; N Fusetani; P L Fuchs
Journal:  Bioorg Med Chem Lett       Date:  1999-09-06       Impact factor: 2.823

6.  Isolation, structure elucidation, and antitumor activity of spirohexenolides A and B.

Authors:  MinJin Kang; Brian D Jones; Alexander L Mandel; Justin C Hammons; Antonio G DiPasquale; Arnold L Rheingold; James J La Clair; Michael D Burkart
Journal:  J Org Chem       Date:  2009-12-04       Impact factor: 4.354

7.  Ammosamides A and B target myosin.

Authors:  Chambers C Hughes; John B MacMillan; Susana P Gaudêncio; William Fenical; James J La Clair
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 8.  Hybrid molecules with a dual mode of action: dream or reality?

Authors:  Bernard Meunier
Journal:  Acc Chem Res       Date:  2007-08-01       Impact factor: 22.384

9.  Syntheses of the eastern halves of ritterazines B, F, G, and H, leading to reassignment of the 5,5-spiroketal stereochemistry of ritterazines B and F.

Authors:  Scott T Phillips; Matthew D Shair
Journal:  J Am Chem Soc       Date:  2007-05-01       Impact factor: 15.419

10.  Ritterazine B, a new cytotoxic natural compound, induces apoptosis in cancer cells.

Authors:  Takefumi Komiya; Nobuhiro Fusetani; Shigeki Matsunaga; Akihito Kubo; Frederic J Kaye; Michael J Kelley; Kenji Tamura; Makoto Yoshida; Masahiro Fukuoka; Kazuhiko Nakagawa
Journal:  Cancer Chemother Pharmacol       Date:  2003-01-14       Impact factor: 3.333

View more
  3 in total

1.  Ritterostatin GN 1N , a Cephalostatin-Ritterazine Bis-steroidal Pyrazine Hybrid, Selectively Targets GRP78.

Authors:  Andrew J Ambrose; Evelyne A Santos; Paula C Jimenez; Danilo D Rocha; Diego V Wilke; Paolo Beuzer; Josh Axelrod; Ananda Kumar Kanduluru; Philip L Fuchs; Hu Cang; Letícia V Costa-Lotufo; Eli Chapman; James J La Clair
Journal:  Chembiochem       Date:  2017-02-02       Impact factor: 3.164

2.  The cephalostatins. 22. synthesis of bis-steroidal pyrazine pyrones (1).

Authors:  George R Pettit; Bryan R Moser; Ricardo F Mendonça; John C Knight; Fiona Hogan
Journal:  J Nat Prod       Date:  2012-05-18       Impact factor: 4.050

3.  A convergent total synthesis of the potent cephalostatin/ritterazine hybrid -25-epi ritterostatin GN1N.

Authors:  Ananda Kumar Kanduluru; Prabal Banerjee; John A Beutler; Philip L Fuchs
Journal:  J Org Chem       Date:  2013-08-29       Impact factor: 4.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.